Moderna said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot for the virus in a late-stage trial.

A Senate committee will vote this week on whether to advance the nomination of Susan Monarez, President Donald Trump’s pick ...

Amidst an ongoing outbreak of a deadly bird flu virus in livestock, the US Department of Agriculture is doing more to prevent the spread than public health agencies are ...

U.S. Senate Democrats demanded on Wednesday Health Secretary Robert F. Kennedy Jr. make public the reviews on which his department said it based its decision to cancel a contract for developing a ...

Two large US investments in human vaccines for the H5N1 avian flu are aimed at improving readiness in the case of a pandemic. The US Department of Health and Human Services (HHS), through the ...

US regulators recently told the company that it needed to produce flu vaccine efficacy data — and not just data on the immune response — delaying a potential approval for a combination shot ...

By Madison Muller, Bloomberg News (TNS) U.S. health officials are terminating a $590 million contract with Moderna Inc. to develop vaccines for bird flu, a major setback for the company that’s ...

A UB study found that the vaccine platform, proven effective for COVID-19, could be key in responding to evolving bird flu strains.

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

By Ahmed Aboulenein WASHINGTON (Reuters) -U.S. Senate Democrats demanded on Wednesday Health Secretary Robert F. Kennedy Jr. make public the reviews on which his department said it based its ...

Moderna said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot for the virus in a late-stage trial.